The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
Open accessAbstract
Microbe–host communication is essential to maintain vital functions of a healthy host, and its disruption has been associated with several diseases, including Crohn’s disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD). Although individual members of the intestinal microbiota have been associated with experimental IBD, identifying microorganisms that affect disease susceptibility and phenotypes in humans remains a considerable challenge. Currently, the lack of a definition between what is healthy and what is a dysbiotic gut microbiome limits research. Nevertheless, although clear proof-of-concept of causality is still lacking, there is an increasingly evident need to understand the microbial basis of IBD at the microbial strain, genomic, epigenomic, and functional levels and in specific clinical contexts. Recent information on the role of diet and novel environmental risk factors affecting the gut microbiome has direct implications for the immune response that impacts the development of IBD. The complexity of IBD pathogenesis, involving multiple distinct elements, suggests the need for an integrative approach, likely utilizing computational modeling of molecular datasets to identify more specific therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–238 of 238
Epigenetics, DNA Organization, and Inflammatory Bowel Disease
Ray, G., & Longworth, M. S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy330 · Cited by 70
Aniwan, S., Tremaine, W. J., Raffals, L. E., Kane, S. V., & Loftus, E. V. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx135 · Cited by 69
Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases
TLASKALOVÁ-HOGENOVÁ, H., TUCKOVÁ, L., STEPÁNKOVÁ, R., HUDCOVIC, T., PALOVÁ-JELÍNKOVÁ, L., KOZÁKOVÁ, H., ROSSMANN, P., SANCHEZ, D., CINOVÁ, J., HRNČÍŘ, T., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.122 · Cited by 68
Genetics and epigenetics of inflammatory bowel disease
Wawrzyniak, M., & Scharl, M. M. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14671 · Cited by 66
Natural environments in the urban context and gut microbiota in infants
Nielsen, C. C., Gascón, M., Osornio-Vargas, Á. R., Shier, C. J., Guttman, D. S., Becker, A. B., Azad, M. B., Sears, M. R., Lefebvre, D. L., Moraes, T. J., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105881 · Cited by 66
Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
Zhuang, X., Liu, C., Zhan, S., Tian, Z., Li, N., Mao, R., Zeng, Z., & Chen, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.626232 · Cited by 65
Nanini, H. F., Bernardazzi, C., Castro, F., & de Souza, H. S. P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i41.4622 · Cited by 59
C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut
Li, T.-H., Liu, L., Hou, Y.-Y., Shen, S.-N., & Wang, T.-T. (2019) · Gastroenterology Report · doi:10.1093/gastro/goz028 · Cited by 58
Epidemiology of Allergy: Natural Course and Risk Factors of Allergic Diseases
Genuneit, J., & Standl, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_507 · Cited by 57
de Bruyn, J. R., van Heeckeren, R., Ponsioen, C. Y., van den Brink, G. R., Löwenberg, M., Bredenoord, A. J., Frijstein, G., & D’Haens, G. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.03.004 · Cited by 56
Inflammatory Bowel Disease: Dysfunction of Autophagy?
Scharl, M. M., & Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000342588 · Cited by 53
Microbial pathogenesis in inflammatory bowel diseases
Kumar, S., & Kumar, A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105383 · Cited by 53
Sewell, G. W., Hannun, Y. A., Han, X., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.016 · Cited by 52
Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohnʼs disease
Sibartie, S., Scully, P., Keohane, J., OʼNeill, S., O’Mahony, J., O'Hanlon, D., Kirwan, W. O., O’Mahony, L., & Shanahan, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21052 · Cited by 51
Linking Immunity, Epigenetics, and Cancer in Inflammatory Bowel Disease
Däbritz, J., & Menheniott, T. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000063 · Cited by 48
Evidence from Genetics for a Role of Autophagy and Innate Immunity in IBD Pathogenesis
Parkes, M. (2012) · Digestive Diseases · doi:10.1159/000338119 · Cited by 48
Yu, R. Y.-L., & Gallagher, G. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002410 · Cited by 45
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease
Spalinger, M. R., McCole, D. F., Rogler, G., & Scharl, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1034 · Cited by 43
Potential Role of Omega-3 Polyunsaturated Fatty Acids in Pediatric Food Allergy
Sartorio, M. U. A., Pendezza, E., Coppola, S., Paparo, L., D’Auria, E., Zuccotti, G., & Canani, R. B. (2021) · Nutrients · doi:10.3390/nu14010152 · Cited by 42
Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
Cui, G., Liu, H., Xu, G., Laugsand, J.-B., & Pang, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757025 · Cited by 41
Riaz, T., Sollid, L. M., Olsen, I., & de Souza, G. A. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.050138 · Cited by 39
Defective macrophage handling of E scherichia coli in C rohn's disease
Elliott, T., Hudspith, B. N., Rayment, N. B., Prescott, N. J., Petrovska, L., Hermon-Taylor, J., Brostoff, J., Boussioutas, A., Mathew, C. G., & Sanderson, J. D. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12955 · Cited by 38
Epigenome-metabolome-microbiome axis in health and IBD
Amatullah, H., & Jeffrey, K. L. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.08.005 · Cited by 38
Elguezábal, N., Chamorro, S., Molina, E., Garrido, J. M., Izeta, A., Rodrigo, L., & Juste, R. A. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-6 · Cited by 37
The Crohn's disease: associated ATG16L1 variant andSalmonellainvasion
Messer, J. S., Murphy, S. F., Logsdon, M. F., Lodolce, J. P., Grimm, W. A., Bartulis, S. J., Vogel, T. P., Burn, M., & Boone, D. L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002790 · Cited by 36
Recent advances in gut immunology
Powell, N., & MacDonald, T. T. (2017) · Parasite Immunology · doi:10.1111/pim.12430 · Cited by 35
Duguet, F., Locard‐Paulet, M., Marcellin, M., Chaoui, K., Bernard, I., Andréoletti, O., Lesourne, R., Burlet‐Schiltz, O., de Peredo, A. G., & Saoudi, A. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.062745 · Cited by 35
LRRK2 and Nod2 promote lysozyme sorting in Paneth cells
da Rocha, J. D. B., Schlossmacher, M. G., & Philpott, D. J. (2015) · Nature Immunology · doi:10.1038/ni.3255 · Cited by 30
Nkamga, V. D., Lotte, R., Chirio, D., Lonjon, M., Roger, P., Drancourt, M., & Ruimy, R. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.021 · Cited by 30
Challenges for Epigenetic Research in Inflammatory Bowel Diseases
Kellermayer, R. (2017) · Epigenomics · doi:10.2217/epi-2016-0155 · Cited by 27
Exploring the Genetic Diversity of the 16S rRNA Gene of Akkermansia Muciniphila in IBD and IBS
Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Cella, E., Putignani, L., Guarino, M. P. L., Monteleone, G., Cicala, M., Angeletti, S., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0175 · Cited by 27
Clostridium difficile in Inflammatory Bowel Disease: A Retrospective Study
Gillespie, W., Marya, N. B., Fahed, J., Leslie, G. J., Patel, K., & Cave, D. R. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/4803262 · Cited by 26
Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells
Ebihara, T. (2020) · Cells · doi:10.3390/cells9051193 · Cited by 22
Moreira, A. D. L., de Campos‐Lobato, L. F., Moreira, J. P. D. L., Luiz, R. R., Elia, C. C. S., Fiocchi, C., & de Souza, H. S. P. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab346 · Cited by 21
Probiotics in the management of ulcerative colitis.
Fedorak, R. N. (2010) · PubMed · Cited by 20
Hygiene hypothesis in inflammatory bowel disease.
Saidel‐Odes, L., & Odes, S. H. (2014) · PubMed · Cited by 14
MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production through Suppression of Blimp1
Yang, W., Chen, L., Xu, L., Bilotta, A. J., Yao, S., Liu, Z., & Cong, Y. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100017 · Cited by 14
Ngoc, B. V. T., Hai, H. B., Galazzo, G., Vu, D. T. V., Oomen, M., Minh, T. N. N., Huy, H. T., van Doorn, H. R., Wertheim, H. F. L., & Penders, J. (2021) · Microorganisms · doi:10.3390/microorganisms9102115 · Cited by 6
Cited by
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease
Shin, Y., Han, S., Kwon, J., Ju, S., Choi, T., Kang, I., & Kim, S. (2023) · Nutrients · doi:10.3390/nu15204466 · Cited by 272
AI in microbiome‐related healthcare
Probul, N., Huang, Z., Saak, C. C., Baumbach, J., & List, M. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70027 · Cited by 36
Metadata
- Authors
- Santana, P. T., Rosas, S. L. B., Ribeiro, B. E., Marinho, Y., & de Souza, H. S. P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-23
- Volume
- 23
- Issue
- 7
- Pages
- 3464
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4223576130
- Cited by
- 325
- References
- 238
- Type
- dissertation
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.